Simulated Cancer Treatment Room For Radiotherapy Students At Kingston And St. George’s Universities, London

Radiotherapy students at Kingston University and St George’s, University of London are set to be among the first in the country to hone their clinical skills in a simulated cancer treatment room. They will start the academic year completing practical elements of their course in a new Virtual Environment for Radiotherapy Training (VERT) suite, which [...]

Mayo Clinic Discovery May Help Diabetic Gastric Problem

Mayo Clinic researchers have found what may provide a solution to one of the more troubling complications of diabetes — delayed gastric emptying or gastroparesis. The researchers showed in animal models that a red blood [...]

Debiopharm Moves Towards A New 6-Month Formulation Of Decapeptyl(R) To Further Help Prostate Cancer Patients

Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, announces the filing of an application with the European Agencies for the approval of its new 6-month formulation of Decapeptyl(R) (triptorelin pamoate [...]

Invivodata Captures Symptom Relief Data In Endometriosis Trial

Invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, announced that its DiaryPRO(R) field-based ePRO system was used to capture important secondary efficacy endpoint data in Neurocrine Biosciences’ (Nasdaq: NBIX) PETAL study, a [...]

Analysis Of Earlier European Stroke Trial Supports Treatment Regimen For Viprinex(TM) In Current International Phase 3 Clinical Trials

Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII) announced that previously found excess symptomatic intracranial hemorrhage in an earlier European trial of ancrod (now Viprinex(TM)) for the treatment of acute ischemic stroke may be minimized with avoidance of prolonged low levels of fibrinogen and use of common blood pressure entry criteria.